India · Delayed Price · Currency is INR Crop Life Science Statistics
Total Valuation
NSE:CLSL has a market cap or net worth of INR 754.16 million. The enterprise value is 1.32 billion.
| Market Cap | 754.16M |
| Enterprise Value | 1.32B |
Important Dates
The last earnings date was Tuesday, May 26, 2026.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:CLSL has 17.14 million shares outstanding. The number of shares has increased by 2.14% in one year.
| Current Share Class | 17.14M |
| Shares Outstanding | 17.14M |
| Shares Change (YoY) | +2.14% |
| Shares Change (QoQ) | +64.35% |
| Owned by Insiders (%) | 35.84% |
| Owned by Institutions (%) | n/a |
| Float | 11.00M |
Valuation Ratios
The trailing PE ratio is 11.61.
| PE Ratio | 11.61 |
| Forward PE | n/a |
| PS Ratio | 0.36 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 0.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 19.93 |
| EV / Sales | 0.64 |
| EV / EBITDA | 7.44 |
| EV / EBIT | 10.30 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.64.
| Current Ratio | 1.55 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 3.18 |
| Debt / FCF | -5.92 |
| Interest Coverage | 2.36 |
Financial Efficiency
Return on equity (ROE) is 7.67% and return on invested capital (ROIC) is 6.40%.
| Return on Equity (ROE) | 7.67% |
| Return on Assets (ROA) | 4.12% |
| Return on Invested Capital (ROIC) | 6.40% |
| Return on Capital Employed (ROCE) | 13.63% |
| Weighted Average Cost of Capital (WACC) | 6.39% |
| Revenue Per Employee | 9.87M |
| Profits Per Employee | 315,957 |
| Employee Count | 210 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 2.53 |
Taxes
In the past 12 months, NSE:CLSL has paid 27.37 million in taxes.
| Income Tax | 27.37M |
| Effective Tax Rate | 29.65% |
Stock Price Statistics
The stock price has decreased by -10.84% in the last 52 weeks. The beta is 0.34, so NSE:CLSL's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -10.84% |
| 50-Day Moving Average | 44.80 |
| 200-Day Moving Average | 51.00 |
| Relative Strength Index (RSI) | 50.56 |
| Average Volume (20 Days) | 7,700 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:CLSL had revenue of INR 2.07 billion and earned 66.35 million in profits. Earnings per share was 3.79.
| Revenue | 2.07B |
| Gross Profit | 558.03M |
| Operating Income | 128.36M |
| Pretax Income | 92.32M |
| Net Income | 66.35M |
| EBITDA | 177.77M |
| EBIT | 128.36M |
| Earnings Per Share (EPS) | 3.79 |
Balance Sheet
The company has 34.82 million in cash and 565.67 million in debt, with a net cash position of -530.84 million or -30.97 per share.
| Cash & Cash Equivalents | 34.82M |
| Total Debt | 565.67M |
| Net Cash | -530.84M |
| Net Cash Per Share | -30.97 |
| Equity (Book Value) | 880.01M |
| Book Value Per Share | 38.70 |
| Working Capital | 628.66M |
Cash Flow
In the last 12 months, operating cash flow was -76.31 million and capital expenditures -19.23 million, giving a free cash flow of -95.54 million.
| Operating Cash Flow | -76.31M |
| Capital Expenditures | -19.23M |
| Depreciation & Amortization | 49.42M |
| Net Borrowing | 273.78M |
| Free Cash Flow | -95.54M |
| FCF Per Share | -5.57 |
Margins
Gross margin is 26.94%, with operating and profit margins of 6.20% and 3.20%.
| Gross Margin | 26.94% |
| Operating Margin | 6.20% |
| Pretax Margin | 4.46% |
| Profit Margin | 3.20% |
| EBITDA Margin | 8.58% |
| EBIT Margin | 6.20% |
| FCF Margin | n/a |
Dividends & Yields
NSE:CLSL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.14% |
| Shareholder Yield | -2.14% |
| Earnings Yield | 8.80% |
| FCF Yield | -12.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |